Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38084760

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2024 Jan 25
First author
Sonneveld P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2024 Apr 18;390(15):1440. doi: 10.1056/NEJMc2402133.
    note
    Source null
    related pmid
    38631009
    relationship
    Comment in
  2. citation
    N Engl J Med. 2024 Apr 18;390(15):1440-1441. doi: 10.1056/NEJMc2402133.
    note
    Source null
    related pmid
    38631010
    relationship
    Comment in

Authors and identifiers

  1. name
    Sonneveld P
    type
    Author
  2. name
    Dimopoulos MA
    type
    Author
  3. name
    Boccadoro M
    type
    Author
  4. name
    Quach H
    type
    Author
  5. name
    Ho PJ
    type
    Author
  6. name
    Beksac M
    type
    Author
  7. name
    Hulin C
    type
    Author
  8. name
    Antonioli E
    type
    Author
  9. name
    Leleu X
    type
    Author
  10. name
    Mangiacavalli S
    type
    Author
  11. name
    Perrot A
    type
    Author
  12. name
    Cavo M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sonneveld P
    type
    Author
  2. name
    Dimopoulos MA
    type
    Author
  3. name
    Boccadoro M
    type
    Author
  4. name
    Quach H
    type
    Author
  5. name
    Ho PJ
    type
    Author
  6. name
    Beksac M
    type
    Author
  7. name
    Hulin C
    type
    Author
  8. name
    Antonioli E
    type
    Author
  9. name
    Leleu X
    type
    Author
  10. name
    Mangiacavalli S
    type
    Author
  11. name
    Perrot A
    type
    Author
  12. name
    Cavo M
    type
    Author
bibliography ids
  1. nci-bib-3288de48cc865285516038ca
book metadata
content sha256
6097861475b212cce1d098b93dd0d52634360ad53ff372ae7661552a662a482c
document type
citation
dois
  1. 10.1056/NEJMoa2312054
electronic publication date
display
2023 Dec 12
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:38084760
immutable id
pubmed:38084760@6097861475b212cce1d098b93dd0d52634360ad53ff372ae7661552a662a482c
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
4
name
The New England journal of medicine
nlm unique id
0255562
pages
301-313
volume
390
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2024 Apr 18;390(15):1440. doi: 10.1056/NEJMc2402133.
    note
    Source null
    related pmid
    38631009
    relationship
    Comment in
  2. citation
    N Engl J Med. 2024 Apr 18;390(15):1440-1441. doi: 10.1056/NEJMc2402133.
    note
    Source null
    related pmid
    38631010
    relationship
    Comment in
outcomes validated
false
pmid
38084760
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
ae821cb61d97a2c5da510bc73bbb330d8630d08f38157cd613995df01578354b
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Jan 25
precision
day
year
2024
publication types
  1. Clinical Trial, Phase III
  2. Randomized Controlled Trial
  3. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38084760/
title
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

Preserved source evidence · Not medical advice